Ultra-thin nanosheets (2-6 nm) of the (Y1-xEux)2(OH)5NO3·nH2O layered rare-earth hydroxide (LRH), directly crystallized without exfoliation were employed for the first time as a sacrificial precursor to synthesize (Y1-xEux)PO4 orthophosphate red phosphors via nano-conversion, and anion exchange of both the hydroxyls and NO3(-) in the LRH with the phosphate ions from diammonium hydrogen phosphate ((NH4)2HPO4) is discussed. Detailed characterization of the materials was performed by the combined techniques of XRD, FTIR, TG/DSC, FE-SEM, HR-TEM, and photoluminescence spectroscopy. The (Y1-xEux)PO4 phosphors, with crystallite sizes of up to ∼20 nm, were found to exhibit stronger (5)D0 → (7)F2 (621 nm) than (5)D0 → (7)F1 (595 nm) emissions under charge transfer excitation (236 nm) owing to the nano-size effect. The optimal Eu(3+) content was determined to be ∼10 at% (x = 0.10), and concentration quenching of luminescence was analyzed to result from exchange interactions. The effects of the Eu(3+) content and annealing temperature on the structural features and luminescence properties of the (Y1-xEux)PO4 nanophosphors were discussed in detail, including emission intensity, the asymmetry factor of luminescence, fluorescence lifetime, and CIE chromaticity coordinates.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: